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Abstract 
Compresses containing a nonsteroidal antiinflammatory drug (NSAID) are commonly 
used in Japan. However, this treatment may induce both allergic and photoallergic 
contact dermatitis from the NSAIDs and their ingredients. Here, we describe a case of 
allergic contact dermatitis with diffuse erythematous reaction due to 
diisopropanolamine in the applied compress. The absorption of diisopropanolamine 
might have been enhanced by the occlusive condition. 
Introduction 
Compresses containing a nonsteroidal antiinflammatory drug (NSAID) are frequently 
used in Japan. However, the style of the application may induce both allergic and 
photoallergic contact dermatitis from the NSAIDs and their ingredients [1–3]. We 
describe a case of allergic contact dermatitis with diffuse erythematous reaction caused by 
allergic sensitivity to a component, diisopropanolamine, of a compress used by the 
patient. 
Case Report 
An 87-year-old Japanese man with dementia presented with a pruritic eruption following the use of 
compresses for lumbago. The patient had used the same compresses for three weeks. During the last ten 
days of use, pruritic eruptions appeared on the bilateral lower back and upper buttock where the 
compresses were being applied. Then, diffuse erythema developed on the trunk and extremities. 
Physical examination revealed rectangular-shaped, pruritic exudative erythematous macular lesions on  
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the bilateral lower back and upper buttock and diffuse erythema on the chest, abdomen, back and 
extremities (fig. 1). The dermatitis was treated with topical steroids. 
A patch test (International Contact Dermatitis Research Group criteria; Finn Chambers on 
Scanpor tape, Epitest Ltd., Tuusula, Finland) was performed with the compress’ ingredients and the 
Japanese baseline series. The manufacturer provided the ingredients. The positive reactions at both 2 
and 4 days after application were to diisopropanolamine 1% pet., fragrance mix 8% pet. (brial allergen 
GmbH, Greven, Germany), and mercuric chloride 0.05% aq. (Torii Pharmaceutical Co., Ltd., Tokyo, 
Japan) (+ on D2 and D4) (fig. 2). 
Discussion 
The patient showed allergic sensitivity to diisopropanolamine in the compresses he 
had used. We believe that sensitization occurred while using the compresses. 
Diisopropanolamine has a relatively low sensitization potential. It is used in emulsifying 
agents for cosmetic lotions, neutralizers in cosmetics, and bath preparations [1]. Until 
now, eight cases of allergic contact dermatitis from diisopropanolamine, including the 
present case, have been described (table 1) [1–6]. Notably, five of the eight cases were 
sensitized from using the compress [1–3]. The absorption of diisopropanolamine may 
have been enhanced by the occlusive condition. 
We previously reported a case of diffuse erythematic reaction after using compresses 
[2]. In the previous case, three concomitant sensitizations to diisopropanolamine, 
felbinac, and crotamiton supposedly caused a diffuse erythematic reaction [2]. In the 
present case, a single sensitization to diisopropanolamine was associated with a diffuse 
erythema. 
Thus, similar phenomena of allergic contact dermatitis with diffuse erythematous 
reaction may be caused by allergic sensitivity to a different component or different 
combinations of ingredients in the topical medicament. Patch testing with full ingredients 
from the manufacturer is essential for detecting the sensitized allergens in each case. 
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Table 1. Cases of allergic contact dermatitis due to diisopropanolamine 
Case Age/ 
sex 
Clinical feature    Allergen(s)  Products used by 
the patient 
Present case  87/M  rectangular-shaped, pruritic 
exudative erythematous macular 
lesions with diffuse erythema 
 diisopropanolamine  compress 
containing 
felbinac 
Umebayashi,  
2005 [1], 1st case 
78/F  pruritic erythematous erythema     diisopropanolamine  compress 
containing 
felbinac 
Umebayashi,  
2005 [1], 2nd case 
76/F erythema  and  papules    diisopropanolamine  compress 
containing 
felbinac 
Oiso et al.,  
2003 [2]  
65/M rectangular-shaped,  pruritic 
exudative erythematous macular 
lesions with diffuse erythema 
 diisopropanolamine,  felbinac,  and 
crotamiton 
compress 
containing 
felbinac 
Umebayashi,  
2000 [3] 
45/M rectangular-shaped,  pruritic 
exudative erythema 
 diisopropanolamine  compress 
containing 
felbinac 
Hosokawa et al.,  
1993 [4] 
31/F  pruritic exudative erythema    ketoprofen and oxybenzone as 
photoallergens, and 
diisopropanolamine and 
polyoxyethyleneoreil eter as allergens 
a topical lotion 
Fujimoto et al.,  
1989 [5] 
60/M  severely pruritic diffuse and 
edematous erythema 
 diisopropanolamine  a  topical 
ointment 
Cronin, 1980 [6]  ?/F  ?    diisopropanolamine  a blushing gel 
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Fig. 1. Rectangular-shaped erythema on the bilateral lower back and the buttock and a diffuse 
erythema on the trunk and extremities. 
 
 
 
Fig. 2. Patch testing showed positive reaction to diisopropanolamine on day 4. 
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